Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice
- PMID: 11099471
- DOI: 10.1096/fj.00-0073com
Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice
Abstract
It has been postulated that an inflammatory response after cutaneous wounding is a prerequisite for healing, and inflammatory cytokines, such as interleukin-6 (IL-6), might be intimately involved in this process. IL-6-deficient transgenic mice (IL-6 KO) displayed significantly delayed cutaneous wound healing compared with wild-type control animals, requiring up to threefold longer to heal. This was characterized by minimal epithelial bridge formation, decreased inflammation, and granulation tissue formation. Using electrophoretic mobility shift assays of wound tissue from IL-6 KO mice, decreased AP-1 transcription factor activation was shown compared with wild-type mice 16 h after wounding. In situ hybridization of wound tissue from wild-type mice revealed IL-6 mRNA expression primarily in the epidermis at the leading edge of the wound. Delayed wound healing in IL-6 KO mice was reversed with a single dose of recombinant murine IL-6 or intradermal injection of an expression plasmid containing the full-length murine IL-6 cDNA. Treatment with rmIL-6 also reconstituted wound healing in dexamethasone-treated immunosuppressed mice. The results of this study may indicate a potential use for IL-6 therapeutically where cutaneous wound healing is impaired.
Similar articles
-
Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice.J Interferon Cytokine Res. 2001 Aug;21(8):603-9. doi: 10.1089/10799900152547867. J Interferon Cytokine Res. 2001. PMID: 11559438
-
Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing.Biochem Biophys Res Commun. 1999 Nov;265(1):194-9. doi: 10.1006/bbrc.1999.1455. Biochem Biophys Res Commun. 1999. PMID: 10548513
-
Impaired cutaneous wound healing with excess granulation tissue formation in TNFalpha-null mice.Arch Dermatol Res. 2009 Aug;301(7):531-7. doi: 10.1007/s00403-009-0969-z. Epub 2009 Jun 20. Arch Dermatol Res. 2009. PMID: 19543902
-
IL-17 Control of Cutaneous Immune Homeostasis.J Invest Dermatol. 2024 Jun;144(6):1208-1216. doi: 10.1016/j.jid.2023.11.016. Epub 2024 Apr 26. J Invest Dermatol. 2024. PMID: 38678465 Review.
-
The Role of IL-6 in Skin Fibrosis and Cutaneous Wound Healing.Biomedicines. 2020 Apr 30;8(5):101. doi: 10.3390/biomedicines8050101. Biomedicines. 2020. PMID: 32365896 Free PMC article. Review.
Cited by
-
Limited Treatment Options for Diabetic Wounds: Barriers to Clinical Translation Despite Therapeutic Success in Murine Models.Adv Wound Care (New Rochelle). 2021 Aug;10(8):436-460. doi: 10.1089/wound.2020.1254. Epub 2020 Dec 18. Adv Wound Care (New Rochelle). 2021. PMID: 33050829 Free PMC article.
-
Subfractions of enamel matrix derivative differentially influence cytokine secretion from human oral fibroblasts.J Tissue Eng. 2015 Mar 19;6:2041731415575857. doi: 10.1177/2041731415575857. eCollection 2015. J Tissue Eng. 2015. PMID: 26090085 Free PMC article.
-
Tissue regeneration using macrophage migration inhibitory factor-impregnated gelatin microbeads in cutaneous wounds.Am J Pathol. 2005 Dec;167(6):1519-29. doi: 10.1016/S0002-9440(10)61238-2. Am J Pathol. 2005. PMID: 16314467 Free PMC article.
-
Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy.Langenbecks Arch Surg. 2008 May;393(3):423-5. doi: 10.1007/s00423-007-0217-y. Epub 2007 Aug 17. Langenbecks Arch Surg. 2008. PMID: 17703320
-
Purification of PaTx-II from the Venom of the Australian King Brown Snake and Characterization of Its Antimicrobial and Wound Healing Activities.Int J Mol Sci. 2023 Feb 22;24(5):4359. doi: 10.3390/ijms24054359. Int J Mol Sci. 2023. PMID: 36901790 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials